DS 121

Drug Profile

DS 121

Latest Information Update: 11 Jan 1999

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Pharmacia Corporation
  • Class Antidepressants; Antipsychotics; Small molecules
  • Mechanism of Action Dopamine D2 receptor antagonists; Dopamine D3 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Drug abuse; Major depressive disorder; Schizophrenia

Most Recent Events

  • 11 Jan 1999 Discontinued-Preclinical for Drug abuse in USA (Unknown route)
  • 10 Feb 1998 Discontinued-Preclinical for Depression in USA (Unknown route)
  • 10 Feb 1998 Discontinued-Preclinical for Schizophrenia in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top